Kümpfel, Tania http://orcid.org/0000-0001-7509-5268
Giglhuber, Katrin
Aktas, Orhan
Ayzenberg, Ilya
Bellmann-Strobl, Judith
Häußler, Vivien
Havla, Joachim
Hellwig, Kerstin
Hümmert, Martin W.
Jarius, Sven
Kleiter, Ingo
Klotz, Luisa
Krumbholz, Markus
Paul, Friedemann
Ringelstein, Marius
Ruprecht, Klemens
Senel, Makbule
Stellmann, Jan-Patrick
Bergh, Florian Then
Trebst, Corinna
Tumani, Hayrettin
Warnke, Clemens
Wildemann, Brigitte
Berthele, Achim
Albrecht, Philipp
Angstwurm, Klemens
Asseyer, Susanna
Gomes, Ana Beatriz Ayroza Galvao Ribeiro
Bayas, Antonios
Behnke, Stefanie
Bittner, Stefan
Buetow, Franziska
Buttmann, Mathias
Duchow, Ankelien
Engels, Daniel
Etgen, Thorleif
Fischer, Katinka
Frank, Benedikt
Gahlen, Anna
Gass, Achim
Gehring, Johannes
Geis, Christian
Gold, Ralf
Göreci, Yasemin
Graf, Jonas
Groppa, Sergiu
Grothe, Matthias
Gutbrod, Julia
Guthke, Kersten
Haarmann, Axel
Hastermann, Maria
Hemmer, Bernhard
Herfurth, Mariella
Herwerth, Marina
Hoffmann, Frank
Hoffmann, Olaf
Hümmert, Martin W
Husseini, Leila
Junghans, Jutta
Kaste, Matthias
Kern, Peter
Kern, Karsten
Kermer, Pawel
Kleinschnitz, Christoph
Köhler, Wolfgang
Körbel, Kimberly
Kowarik, Markus
Kraemer, Markus
Kretschmer, Julian
Kurka, Natalia
Ladopoulus, Theodoros
Lauenstein, Ann-Sophie
Laurent, Sarah
Lee, De-Hyung
Lehrieder, Dominik
Leypoldt, Frank
Liebetrau, Martin
Linker, Ralf
Lindenblatt, Gero
Lohmann, Lisa
Lüssi, Felix
Luedemann, Peter
Maiworm, Michelle
Marziniak, Martin
Mayer, Christoph
Meister, Stefanie
Mering, Mathias
Metz, Imke
Meuth, Sven
Naumann, Jasmin
Neuhaus, Oliver
Neziraj, Tradite
Niederschweiberer, Moritz
Niehaus, Sabine
Otto, Carolin
Pache, Florence
Pakeerathan, Thivya
Passoke, Sarah
Pawlitzki, Marc
Pellkofer, Hannah
Pompsch, Mosche
Pröbstel, Anne-Katrin
Pul, Refik
Rauer, Sebastian
Retzlaff, Nele
Riedlinger, Arne
Rommer, Paulus
Rothhammer, Veith
Rostásy, Kevin
Rust, Rebekka
Ruschil, Christoph
Schwab, Matthias
Seipelt, Maria
Schindler, Patrick
Schwake, Carolin
Schwarz, Patricia
Sommer, Claudia
Stefanou, Alexander
Sprenger, Till
Steinbrecher, Andreas
Stephanik, Heike
Stoppe, Muriel
Stürner, Klarissa
Süße, Marie
Tarampanis, Athanasios
Tauber, Simone
Tkachenko, Daria
Walter, Annette
Wandinger, Klaus-Peter
Walz, Anna
Weber, Martin
Weise, Jens
Wickel, Jonathan
Wiendl, Heinz
Winkelmann, Alexander
Yalachkov, Yavor
Zettl, Uwe
Ziemann, Ulf
Zipp, Frauke
,
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 3 May 2023
Revised: 27 July 2023
Accepted: 27 July 2023
First Online: 7 September 2023
Change Date: 13 October 2023
Change Type: Update
Change Details: The section “Inebilizumab” has been updated within Box 3 instead of processing it separately in the XML and it has been updated
Change Date: 5 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-024-12288-2
Declarations
:
: TK has received speaker honoraria and/or personal fees for advisory boards from Roche Pharma, Alexion/Astra Zeneca, Horizon, Merck, Chugai and Biogen. The Institution she works for has received grant support for her research from Bayer-Schering AG, Novartis and Chugai Pharma in the past. None resulted in a conflict of interest. KG has received travel support from UCB. OA has received speaking honoraria and travel grants from Alexion, Almirall, Biogen, Celgene, Merck, Novartis, Roche, and VielaBio. IA has received speaking honoraria and scientific advisory board compensation from Alexion, Roche, Merck Serono, Santhera, and Sanofi Genzyme and research support from Chugai and Diamed. JBS has received speaking honoraria and travel grants from Bayer Healthcare, sanofiaventis/Genzyme, and Biogen and compensation for serving on a scientific advisory board from Roche. VH reports no conflicts of interest. JH reports a grant for OCT research from the Friedrich-Baur-Stiftung, personal fees and nonfinancial support from Merck, Alexion, Novartis, Roche, Santhera, Biogen, Heidelberg Engineering, and Sanofi Genzyme, and non-financial support from the Guthy-Jackson Charitable Foundation; JH is partially funded by the German Federal Ministry of Education and Research [grant numbers 01ZZ1603[A-D] and 01ZZ1804[A-H] (DIFUTURE)]. KH reports no conflicts of interest. MH reports no conflicts of interest. SJ reports no conflicts of interest. IK has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities from Alexion, Almirall, Bayer, Biogen, Hexal, Horizon, Merck, Neuraxpharm, Sanofi, and Roche/Chugai. LK has received compensation for serving on scientific advisory boards from Alexion, Biogen, BMS, Celgene GmbH, Genzyme, Horizon, Janssen, Merck Serono, Novartis, and Roche. She has received speaker honoraria and travel support from Bayer, Biogen, Celgene GmbH, Genzyme, Grifols, Merck Serono, Novartis, Roche, Santhera, and Teva. She receives research support from the German Research Foundation, the IZKF Münster, IMF Münster, Biogen, Immunic AG, Novartis, and Merck Serono. MK has received travel funding, speaker honoraria, and research support from Bristol Myers Squibb, Merck, Novartis, and Roche. FP has received grants from the Guthy Jackson Charitable Foundation, German Research Foundation, German Federal Ministry of Education and Research, Novartis, Bayer, Novartis, Biogen Idec, Teva, Alexion, Roche, Horizon, Sanofi-Aventis/Genzyme, Merck Serono, Chugai, German Research Council, Werth Stiftung of the City of Cologne, Arthur Arnstein Stiftung Berlin, EU FP7 Framework Program, National Multiple Sclerosis (USA), MedImmune, Shire, and Alexion, and has a patent on Foveal Morphometry pending to Nocturne GmbH; he is Academic Editor at PLoS ONE and Associate Editor of Neurology® Neuroimmunology & Neuroinflammation. MR has received speaker honoraria from Novartis, Bayer Vital GmbH, Roche, Alexion, and Ipsen and travel reimbursement from Bayer Schering, Biogen Idec, Merz, Genzyme, Teva, Roche, and Merck. KR received research support from Novartis Pharma, Merck Serono, German Ministry of Education and Research, European Union (821283–2), Stiftung Charité (BIH Clinical Fellow Program) and Arthur Arnstein Foundation, and received speaker honoraria from Bayer and travel grants from Guthy Jackson Charitable Foundation. MS has received consulting and/or speaker honoraria from Alexion, Bayer, Biogen, Bristol-Myers-Squibb, Merck, Roche, and Sanofi Genzyme. She has received research funding from the Hertha-Nathorff-Program. PS reports no conflict of interest. FTB has received personal compensation for advisory board participation or speaking, and through his institution has received research support for investigator-initiated studies or for attending scientific meetings, from Actelion, Alexion, Bayer-Schering, Biogen, Merck, Novartis, Roche, Sanofi-Genzyme, Teva, UCB, the German Research Foundation (DFG), and the German Federal Ministry of Education and Research (BMBF). CT has received honoraria for consultation and expert testimony from Alexion Pharma Germany GmbH, Chugai Pharma Germany GmbH, and Roche Pharma GmbH HT received research institutional support and/or consulting/speaker honoraria from Alexion, Bayer, Biogen, Bristol-Myers Squibb, Celgene, Diamed, Fresenius, Fujirebio, GlaxoSmithKline, Horizon, Janssen-Cilag, Merck, Novartis, Roche, Sanofi Genzyme, TEVA. His research is also funded by Ministry of Education and Research (BMBF), Ministry of Science, Research and Arts Baden Württemberg (MWK-BW), German Society of Multiple Sclerosis (DMSG), DMS-Stiftung, AMSEL-Stiftung, Bayern-DMSG and Chemische Fabrik Karl Bucher GmbH BW has received grants from the German Ministry of Education and Research, Deutsche Forschungsgemeinschaft, Dietmar Hopp Stiftung, Klaus Tschira Stiftung, and Merck, and personal fees from Alexion, Bayer, Biogen, Roche. CW has received institutional support from Novartis, Alexion, Sanofi Genzyme, Biogen, Merck, and Roche AB has received consulting and/or speaking fees from Alexion, Bayer Healthcare, Biogen, Celgene, Horizon and Roche. His institution has received compensations for clinical trials from Alexion, Biogen, Merck, Novartis, Roche, and Sanofi.
: The manuscript does not contain patient or animal data.